SHA:603229 Market Cap

SHA:603229 has a market cap or net worth of 7.98 billion as of April 29, 2026. Its market cap has increased by 16.43% in one year.

Market Cap

7.98B

Enterprise Value

7.21B

Revenue

794.80M

Ranking

n/a

PE Ratio

71.80

Stock Price

9.64

Market Cap Chart

Since May 9, 2017, SHA:603229's market cap has increased from 1.80B to 7.98B, an increase of 343.60%. That is a compound annual growth rate of 18.06%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	8.43B	2.62%
Dec 31, 2025	8.22B	-0.94%
Dec 31, 2024	8.29B	5.87%
Dec 29, 2023	7.83B	-18.09%
Dec 30, 2022	9.56B	-8.49%
Dec 31, 2021	10.45B	19.25%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Youcare Pharmaceutical Group	8.65B
Daan Gene	8.10B
GemPharmatech	8.00B
Sino Biological,Inc.	8.83B
China Resources Boya Bio-pharmaceutical Group Co.,Ltd	9.05B
Nanjing Vazyme Biotech	7.74B
Shanghai Medicilon	9.12B
Acrobiosystems	7.74B

Market Cap Rankings